Navigation Links
Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
Date:11/8/2012

NEW YORK, Nov. 8, 2012 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of DUSA Pharmaceuticals, Inc. ("DUSA" or the "Company") (NASDAQ: DUSA) concerning the proposed acquisition of the Company by Sun Pharmaceutical Industries Ltd. ("Sun Pharmaceuticals") in a transaction valued at approximately $230 million. 

(Logo:  http://photos.prnewswire.com/prnh/20120215/MM54604LOGO )

On November 8, 2012, it was announced that DUSA and Sun Pharmaceuticals have entered into a definitive agreement pursuant to which Sun Pharmaceuticals will acquire DUSA.  Under the terms of the transaction, DUSA shareholders will receive $8.00 in cash per share held.  At least one analyst has set a target price for DUSA stock of $9.50 per share.

Our investigation concerns whether the DUSA board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company shareholders. 

If you own DUSA shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Benjamin Sachs-Michaels, Esq.

Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising © 2012 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.


'/>"/>
SOURCE Harwood Feffer LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
2. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
3. ActiveCare Announces Record Revenue For Quarter Ending June 30, 2012
4. Echo Therapeutics Announces Third Quarter 2012 Financial Results
5. Concord Medical Announces Change to Third Quarter Financial Results Date to November 20, 2012
6. Winner Medical Announces Mailing of Definitive Proxy Materials for Special Meeting of Shareholders
7. Genoa Pharmaceuticals announces $1.2M Financing
8. Genomic Health Announces Third Quarter 2012 Financial Results and Business Progress
9. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
10. Life Technologies Announces Next-Gen Digital PCR Instrument Designed for Widespread Adoption
11. Blue Belt Technologies Announces First United Kingdom-Based NavioPFS Unicondylar Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
(Date:7/5/2017)... July 5, 2017 Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... has received approval from the Israel Securities Authority to dual-list ... Oramed common stock will commence trading on the TASE on ... current market capitalization of the Company, it is expected that ...
(Date:7/1/2017)... June 30, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... earnings conference call will be broadcast live over the Internet ... A news release detailing the quarterly results will be made ... conference call. The live audio webcast can be ... . It will be archived for replay following the conference ...
Breaking Medicine Technology:
(Date:7/21/2017)... Norwalk, Connecticut (PRWEB) , ... July 21, 2017 , ... ... data from HealthCareMandA.com . The number of hospital acquisitions rose to 23 in ... quarter of 2017, and up 15% from the 20 announced deals in the year-ago ...
(Date:7/21/2017)... ... July 21, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... violence and aggression to solve problems and pleads with world leaders to be more open ... do not bring peace. He says there is a peaceful and positive way to solve ...
(Date:7/21/2017)... ST. LOUIS, MO (PRWEB) , ... July 21, 2017 , ... ... are born knowing how to tie their shoes,” says Suzanne Tucker, Founder of St. ... created the Time-In Toolkit, which launches on Kickstarter on Monday, July 21st. , ...
(Date:7/21/2017)... CANADA (PRWEB) , ... July 21, 2017 , ... ... 80% follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) ... of life a decade after surgery, though activity levels decline over time. The ...
(Date:7/20/2017)... ... ... TransPixel Volume 2 is a set of transitions that create a pixel ... horizontal and vertical lines of pixels and sorts their pixels by darkness, brightness, or ... can be changed using a drop-down menu. Create amazing and artistic transitions using TransPixel ...
Breaking Medicine News(10 mins):